Market Closed -
Nasdaq
03:59:47 2024-06-04 pm EDT
|
5-day change
|
1st Jan Change
|
11.64
USD
|
-10.46%
|
|
-12.81%
|
-49.87%
|
Fiscal Period: February |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Capitalization
1 |
1,492
|
949.5
|
1,034
|
965.1
|
570.5
|
266.9
|
Enterprise Value (EV)
1 |
1,472
|
1,486
|
1,604
|
1,361
|
1,066
|
717.1
|
P/E ratio
|
15.3
x
|
13.5
x
|
-7.39
x
|
5.34
x
|
-518
x
|
-1.73
x
|
Yield
|
2.17%
|
3.55%
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.77
x
|
0.51
x
|
0.68
x
|
0.5
x
|
0.33
x
|
0.17
x
|
EV / Revenue
|
0.76
x
|
0.79
x
|
1.05
x
|
0.71
x
|
0.62
x
|
0.45
x
|
EV / EBITDA
|
7.9
x
|
8.38
x
|
-16.9
x
|
3.96
x
|
20
x
|
49.3
x
|
EV / FCF
|
20.9
x
|
8.79
x
|
-18.1
x
|
10.1
x
|
-32
x
|
6.05
x
|
FCF Yield
|
4.79%
|
11.4%
|
-5.52%
|
9.92%
|
-3.13%
|
16.5%
|
Price to Book
|
4.64
x
|
3.94
x
|
11.1
x
|
4.14
x
|
3.6
x
|
-29.7
x
|
Nbr of stocks (in thousands)
|
16,194
|
15,065
|
14,587
|
14,362
|
12,228
|
12,477
|
Reference price
2 |
92.13
|
63.03
|
70.86
|
67.20
|
46.66
|
21.39
|
Announcement Date
|
3/21/19
|
3/19/20
|
3/29/21
|
3/25/22
|
3/28/23
|
5/6/24
|
Fiscal Period: February |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Net sales
1 |
1,938
|
1,871
|
1,523
|
1,915
|
1,708
|
1,603
|
EBITDA
1 |
186.3
|
177.2
|
-94.98
|
344.1
|
53.19
|
14.53
|
EBIT
1 |
117.4
|
102.4
|
-161.4
|
285.7
|
1.726
|
-30.86
|
Operating Margin
|
6.06%
|
5.47%
|
-10.6%
|
14.91%
|
0.1%
|
-1.93%
|
Earnings before Tax (EBT)
1 |
108.5
|
88.42
|
-211.8
|
257
|
-14.76
|
-113.8
|
Net income
1 |
101
|
73.3
|
-140.4
|
187.2
|
-1.138
|
-154.5
|
Net margin
|
5.21%
|
3.92%
|
-9.22%
|
9.77%
|
-0.07%
|
-9.64%
|
EPS
2 |
6.010
|
4.680
|
-9.594
|
12.59
|
-0.0900
|
-12.36
|
Free Cash Flow
1 |
70.57
|
169.1
|
-88.51
|
135
|
-33.31
|
118.6
|
FCF margin
|
3.64%
|
9.04%
|
-5.81%
|
7.05%
|
-1.95%
|
7.4%
|
FCF Conversion (EBITDA)
|
37.88%
|
95.43%
|
-
|
39.24%
|
-
|
815.94%
|
FCF Conversion (Net income)
|
69.9%
|
230.69%
|
-
|
72.13%
|
-
|
-
|
Dividend per Share
2 |
2.000
|
2.240
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/21/19
|
3/19/20
|
3/29/21
|
3/25/22
|
3/28/23
|
5/6/24
|
Fiscal Period: February |
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
558.2
|
507.8
|
362.4
|
380.9
|
509.1
|
456.1
|
321.6
|
345.6
|
480.2
|
455
|
EBITDA
1 |
130.7
|
75.47
|
34.26
|
1.723
|
165.7
|
-48.82
|
-12.7
|
-13.01
|
59.61
|
-19.21
|
EBIT
1 |
116.5
|
61.21
|
20.64
|
-11.73
|
59.1
|
-60.96
|
-24.55
|
-24.97
|
47.88
|
-30.86
|
Operating Margin
|
20.87%
|
12.05%
|
5.7%
|
-3.08%
|
11.61%
|
-13.37%
|
-7.63%
|
-7.22%
|
9.97%
|
-6.78%
|
Earnings before Tax (EBT)
|
109.9
|
52.53
|
17.55
|
-16.42
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
78.87
|
39
|
19.83
|
-13.3
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
14.13%
|
7.68%
|
5.47%
|
-3.49%
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
5.300
|
2.680
|
1.430
|
-1.010
|
3.260
|
-4.100
|
-2.330
|
-2.820
|
3.050
|
-10.26
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/18/21
|
3/9/22
|
5/19/22
|
8/17/22
|
11/17/22
|
3/16/23
|
5/24/23
|
8/17/23
|
11/16/23
|
5/6/24
|
Fiscal Period: February |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Net Debt
1 |
-
|
536
|
570
|
396
|
495
|
450
|
Net Cash position
1 |
20.3
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
3.026
x
|
-6.005
x
|
1.151
x
|
9.308
x
|
30.98
x
|
Free Cash Flow
1 |
70.6
|
169
|
-88.5
|
135
|
-33.3
|
119
|
ROE (net income / shareholders' equity)
|
25.6%
|
26.7%
|
-85.4%
|
117%
|
-0.59%
|
-207%
|
ROA (Net income/ Total Assets)
|
8.8%
|
6.71%
|
-8.69%
|
16.4%
|
0.11%
|
-2.16%
|
Assets
1 |
1,147
|
1,093
|
1,615
|
1,141
|
-1,068
|
7,159
|
Book Value Per Share
2 |
19.90
|
16.00
|
6.400
|
16.20
|
13.00
|
-0.7200
|
Cash Flow per Share
2 |
4.370
|
4.660
|
4.360
|
3.940
|
1.370
|
1.090
|
Capex
1 |
71.1
|
57.5
|
30.6
|
29.3
|
45.6
|
27.6
|
Capex / Sales
|
3.67%
|
3.07%
|
2.01%
|
1.53%
|
2.67%
|
1.72%
|
Announcement Date
|
3/21/19
|
3/19/20
|
3/29/21
|
3/25/22
|
3/28/23
|
5/6/24
|
Last Close Price
11.67
USD Average target price
24
USD Spread / Average Target +105.66% Consensus |